Skip to main content
. 2021 Jul 13;62(9):2142–2150. doi: 10.1111/epi.17007

FIGURE 3.

FIGURE 3

Patient disposition and reason for discontinuation (open‐label extension [OLE] population). aAn additional three patients completed the OLE as reported on the end of study case report form. The patients completed 9.0 months, 11.0 months, and 12.3 months of treatment in the OLE